Prophylactic oral dolasetron mesylate reduces nausea and vomiting after abdominal hysterectomy

Canadian Journal of Anaesthesia

Volumn 44, Issue 11, 1997, Pages 1167-1173

  Warriner, C B ^a   Knox, D ^k   Belo, S ^k   Cole, C ^k   Finegan, B A ^k   Perreault, L ^k   Kronberg, J E ^b   Hudson, R J ^c   Plourde, G ^d   Murphy, L ^e   Zaharia, F ^f   DuVal, D B ^g   Derkzo, C ^h   Juneau, M ⁱ   McKenzie, K ^j   Keays, S ^j   Dempsey, E ^j  

^a ST PAUL S HOSPITAL   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c ST BONIFACE GENERAL HOSPITAL   (Canada)

^d ROYAL VICTORIA HOSPITAL   (Canada)

^e VANCOUVER GENERAL HOSPITAL   (Canada)

^f CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^g Misericordia Community Hospital   (Canada)

^h ST MICHAEL'S HOSPITAL   (Canada)

ⁱ MONTREAL HEART INSTITUTE   (Canada)

^j Hoechst Marion Roussel Canada R   (Canada)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

DOLASETRON MESILATE; FENTANYL; GLYCOPYRRONIUM BROMIDE; ISOFLURANE; MORPHINE; NEOSTIGMINE; NITROUS OXIDE; PLACEBO; SEROTONIN 3 ANTAGONIST; SUXAMETHONIUM; THIOPENTAL; TUBOCURARINE CHLORIDE; VECURONIUM; VERAPAMIL;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; GENERAL ANESTHESIA; GYNECOLOGIC SURGERY; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPOTENSION; INCIDENCE; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VERTIGO; VOMITING;

EID: 6844265564     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03013339     Document Type: Article

References (25)

1. Williams AR, Hind M, Sweeney BP, Fisher R. The incidence and severity of postoperative nausea and vomiting in patients exposed to positive intra-operative suggestions. Anaesthesia 1994; 49: 340-2.
2. Helmers JHJH, Briggs L, Abrahamsson J, et al. A single iv dose of ondansetron 8 mg prior to induction of anaesthesia reduces postoperative nausea and vomiting in gynaecological patients. Can J Anaesth 1993; 40: 1155-61.
3. Kenny GNC, Oates JDL, Leeser J, et al. Efficacy of orally administered ondansetron in the prevention of postoperative nausea and vomiting: a dose ranging study. Br J Anaesth 1992; 68: 466-70.
4. Alon E, Himmelseher S. Ondansetron in the treatment of postoperative vomiting: a randomized, double-blind comparison with droperidol and metoclopramide. Anesth Analg 1992; 75: 561-5.
5. Orkin FK. What do patients want? - preferences for immediate postoperative recovery. Anesth Analg 1992; 74: S225.
6. Lerman J. Are antiemetics cost-effective for children? (Editorial). Can J Anaesth 1995; 42: 263-6.
7. Carroll NV, Miederhoff P, Cox FM, Hirsch JD. Postoperative nausea and vomiting after discharge from outpatient surgery centers. Anesth Analg 1995; 80: 903-9.
8. Kapur PA. The big "little problem." (Editorial) Anesth Analg 1991; 73: 243-5.
9. Chevallier B, Cappelaere P, Splinter T, et al. IV dolasetron (DM) vs IV metoclopramide (M) in emesis prevention after cisplatin chemotherapy (CT). (Abstract) Supportive Care in Cancer 1995; 3: 16.
10. Del Favero A, Bergerat J, Chemaissani A, et al. Single oral doses of dolasetron versus multiple doses of ondansetron in preventing emesis after moderately emetogenic chemotherapy. (Abstract) Supportive Care in Cancer 1995; 3: 19.
11. 2) chemotherapy. (Abstract) Supportive Care in Cancer 1995; 3: 21.
12. Leclerc JM, Greenberg M, Lau R, et al. Open label IV dolasetron mesylate in pediatric patients receiving moderately to highly emetogenic chemotherapy: pharmacokinetics, efficacy and safety. (Abstract) Supportive Care in Cancer 1995; 3: 37.
13. Bey P, Wilkinson PM, Claverie N, et al. IV dolasetron mesilate in the prevention of radiotherapy-induced nausea and vomiting. (Abstract) Supportive Care in Cancer 1995; 3: 36.
14. Fauser AA. Pilot study of the antiemetic efficacy of dolasetron in leukemia patients receiving total body irradiation (TBI) and chemotherapy before bone-marrow transplantation. (Abstract) Supportive Care in Cancer 1995; 3: 51.
15. Hunt TL, Cramer M, Shah A, Stewart W, Benedict CR, Hahne WF. A double-blind, placebo-controlled, dose-ranging safety evaluation of single-dose intravenous dolasetron in healthy male volunteers. J Clin Pharmacol 1995; 35: 705-12.
16. Kris MG, Grunberg SM, Gralla RJ. et al. Dose-ranging evaluation of the serotonin antagonist dolasetron mesylate in patients receiving high-dose cisplatin. J Clin Oncol 1994; 12:45-9.
17. Kenny GNC. Risk factors for postoperative nausea and vomiting. Anaesthesia 1994; 49(Suppl): 6-10.
18. 3 antagonist ondansetron. Anesthesiology 1993; 78: 15-20.
19. Rust M, Cohen LA. Single oral dose ondansetron in the prevention of postoperative nausea and emesis. Anaesthesia 1994; 49(Suppl): 16-23.
20. Rusthoven J, Pater J, Kaizer L, et al. A randomized, double-blinded study comparing six doses of batanopride (BMY-25801) with methylprednisolone in patients receiving moderately emetogenic chemotherapy. Ann Oncol 1991; 2: 681-6.
21. 3 receptor antagonists, in anesthetized dogs. Drug Develop Res 1991; 24: 277-84.
22. Heyman JS, Young ML, Bagshaw RJ, et al. Cardiovascular stability with rapid intravenous infusion of ondansetron. Can J Anaesth 1993; 40: 448-52.
23. Desilva PHDP, Darvish AH, McDonald SM, Cronin MK, Clark K. The efficacy of prophylactic ondansetron, droperidol, perphenazine, and metoclopramide in the prevention of nausea and vomiting after major gynecologic surgery. Anesth Analg 1995; 81: 139-43.
24. Fujii Y, Tanaka H, Toyooka H. Granisetron-dexamethasone combination reduces postoperative nausea and vomiting. Can J Anaesth 1995; 42: 387-90.
25. Davis PJ, McGowan FX Jr, Landsman I, Maloney K, Hoffmann P. Effect of antiemetic therapy on recovery and hospital discharge time. Anesthesiology 1995; 83: 956-60.